| Primary |
| Prophylaxis Of Nausea And Vomiting |
54.3% |
| Colorectal Cancer |
6.3% |
| Breast Cancer |
5.1% |
| Metastatic Gastric Cancer |
3.9% |
| Premedication |
3.5% |
| Malignant Neoplasm Of Islets Of Langerhans |
3.1% |
| Prophylaxis |
3.1% |
| Colon Cancer Metastatic |
2.4% |
| Colorectal Cancer Metastatic |
2.4% |
| Gastric Cancer |
2.0% |
| Lung Neoplasm Malignant |
2.0% |
| Prostate Cancer |
2.0% |
| Immunosuppressant Drug Therapy |
1.6% |
| Lymphoma |
1.6% |
| Non-small Cell Lung Cancer Metastatic |
1.6% |
| Abdominal Pain |
1.2% |
| Non-hodgkin's Lymphoma |
1.2% |
| Oedema Peripheral |
1.2% |
| Bladder Adenocarcinoma Stage Unspecified |
0.8% |
| Chronic Obstructive Pulmonary Disease |
0.8% |
|
| Vomiting |
17.2% |
| Nausea |
10.9% |
| Rash |
6.3% |
| Syncope |
6.3% |
| Anaphylactoid Reaction |
4.7% |
| Death |
4.7% |
| Hypotension |
4.7% |
| Loss Of Consciousness |
4.7% |
| Scrotal Oedema |
4.7% |
| Unresponsive To Stimuli |
4.7% |
| Bradycardia |
3.1% |
| Dyspnoea |
3.1% |
| Flushing |
3.1% |
| Headache |
3.1% |
| Heart Rate Increased |
3.1% |
| Ileus |
3.1% |
| Oxygen Saturation Decreased |
3.1% |
| Respiratory Disorder |
3.1% |
| Swollen Tongue |
3.1% |
| Tongue Oedema |
3.1% |
|
| Secondary |
| Product Used For Unknown Indication |
19.3% |
| Prophylaxis |
15.2% |
| Breast Cancer |
12.1% |
| Drug Use For Unknown Indication |
9.2% |
| Prophylaxis Of Nausea And Vomiting |
7.8% |
| Nausea |
6.9% |
| Premedication |
4.1% |
| Vomiting |
3.6% |
| Hypertension |
2.6% |
| Colon Cancer |
2.1% |
| Neuroendocrine Tumour |
2.1% |
| Non-hodgkin's Lymphoma |
2.1% |
| Chemotherapy |
1.9% |
| Colorectal Cancer Metastatic |
1.7% |
| Immunosuppressant Drug Therapy |
1.7% |
| Colon Cancer Metastatic |
1.6% |
| Colorectal Cancer |
1.6% |
| Gout |
1.6% |
| Multiple Myeloma |
1.6% |
| Bacterial Infection |
1.4% |
|
| Neuropathy Peripheral |
18.4% |
| Vomiting |
13.8% |
| Jaundice |
9.2% |
| Cardiac Arrest |
4.6% |
| Cardiac Failure Congestive |
4.6% |
| Dyspnoea |
4.6% |
| Febrile Neutropenia |
4.6% |
| Nausea |
4.6% |
| Anaphylactic Reaction |
3.4% |
| Dehydration |
3.4% |
| Drug Ineffective |
3.4% |
| Interstitial Lung Disease |
3.4% |
| Off Label Use |
3.4% |
| Pain In Extremity |
3.4% |
| White Blood Cell Count Decreased |
3.4% |
| Flushing |
2.3% |
| Foetal Exposure During Pregnancy |
2.3% |
| Headache |
2.3% |
| Hypotension |
2.3% |
| Incontinence |
2.3% |
|
| Concomitant |
| Premedication |
13.8% |
| Prophylaxis |
11.3% |
| Product Used For Unknown Indication |
8.6% |
| Colorectal Cancer |
6.9% |
| Drug Use For Unknown Indication |
6.7% |
| Prophylaxis Of Nausea And Vomiting |
6.5% |
| Breast Cancer |
6.5% |
| Non-small Cell Lung Cancer |
5.7% |
| Nausea |
5.3% |
| Hypertension |
4.7% |
| Colon Cancer |
4.6% |
| Pain |
3.8% |
| Colorectal Cancer Metastatic |
2.3% |
| Chemotherapy |
2.3% |
| Breast Cancer Metastatic |
2.1% |
| Constipation |
2.1% |
| Rectal Cancer |
2.0% |
| Anxiety |
1.7% |
| Metastases To Bone |
1.6% |
| Lung Neoplasm Malignant |
1.5% |
|
| Vomiting |
17.6% |
| White Blood Cell Count Decreased |
10.0% |
| Weight Decreased |
9.9% |
| Death |
6.9% |
| Rash |
4.9% |
| Syncope |
4.4% |
| Stomatitis |
4.1% |
| White Blood Cell Count Increased |
4.0% |
| Dyspnoea |
3.8% |
| Pulmonary Embolism |
3.6% |
| Pyrexia |
3.6% |
| Pneumonia |
3.4% |
| Thrombocytopenia |
3.4% |
| Interstitial Lung Disease |
3.2% |
| Nausea |
3.0% |
| Febrile Neutropenia |
2.9% |
| Respiratory Failure |
2.9% |
| Sepsis |
2.9% |
| Infusion Related Reaction |
2.7% |
| Injection Site Phlebitis |
2.7% |
|
| Interacting |
| Prophylaxis Of Nausea And Vomiting |
100.0% |
|
| Infusion Site Extravasation |
33.3% |
| Infusion Site Phlebitis |
33.3% |
| Middle Insomnia |
33.3% |
|
